Unknown

Dataset Information

0

Prolonged oral cannabinoid administration prevents neuroinflammation, lowers ?-amyloid levels and improves cognitive performance in Tg APP 2576 mice.


ABSTRACT: BACKGROUND: Alzheimer's disease (AD) brain shows an ongoing inflammatory condition and non-steroidal anti-inflammatories diminish the risk of suffering the neurologic disease. Cannabinoids are neuroprotective and anti-inflammatory agents with therapeutic potential. METHODS: We have studied the effects of prolonged oral administration of transgenic amyloid precursor protein (APP) mice with two pharmacologically different cannabinoids (WIN 55,212-2 and JWH-133, 0.2 mg/kg/day in the drinking water during 4 months) on inflammatory and cognitive parameters, and on ¹?F-fluoro-deoxyglucose (¹?FDG) uptake by positron emission tomography (PET). RESULTS: Novel object recognition was significantly reduced in 11 month old Tg APP mice and 4 month administration of JWH was able to normalize this cognitive deficit, although WIN was ineffective. Wild type mice cognitive performance was unaltered by cannabinoid administration. Tg APP mice showed decreased ¹?FDG uptake in hippocampus and cortical regions, which was counteracted by oral JWH treatment. Hippocampal GFAP immunoreactivity and cortical protein expression was unaffected by genotype or treatment. In contrast, the density of Iba1 positive microglia was increased in Tg APP mice, and normalized following JWH chronic treatment. Both cannabinoids were effective at reducing the enhancement of COX-2 protein levels and TNF-? mRNA expression found in the AD model. Increased cortical ?-amyloid (A?) levels were significantly reduced in the mouse model by both cannabinoids. Noteworthy both cannabinoids enhanced A? transport across choroid plexus cells in vitro. CONCLUSIONS: In summary we have shown that chronically administered cannabinoid showed marked beneficial effects concomitant with inflammation reduction and increased A? clearance.

SUBMITTER: Martin-Moreno AM 

PROVIDER: S-EPMC3292807 | biostudies-other | 2012

REPOSITORIES: biostudies-other

altmetric image

Publications

Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice.

Martín-Moreno Ana María AM   Brera Begoña B   Spuch Carlos C   Carro Eva E   García-García Luis L   Delgado Mercedes M   Pozo Miguel A MA   Innamorato Nadia G NG   Cuadrado Antonio A   Cuadrado Antonio A   de Ceballos María L ML  

Journal of neuroinflammation 20120116


<h4>Background</h4>Alzheimer's disease (AD) brain shows an ongoing inflammatory condition and non-steroidal anti-inflammatories diminish the risk of suffering the neurologic disease. Cannabinoids are neuroprotective and anti-inflammatory agents with therapeutic potential.<h4>Methods</h4>We have studied the effects of prolonged oral administration of transgenic amyloid precursor protein (APP) mice with two pharmacologically different cannabinoids (WIN 55,212-2 and JWH-133, 0.2 mg/kg/day in the dr  ...[more]

Similar Datasets

| S-EPMC5005718 | biostudies-literature
| S-EPMC8757478 | biostudies-literature
| S-EPMC5725092 | biostudies-literature
| S-EPMC8491854 | biostudies-literature
| S-EPMC8724741 | biostudies-literature
| S-EPMC8770455 | biostudies-literature
| S-EPMC2040315 | biostudies-literature
| S-EPMC4897621 | biostudies-literature
| S-EPMC2190016 | biostudies-other
| S-EPMC4606808 | biostudies-literature